Mapping the future of Neuro-Oncology.

Taking on a successful journal and trying to find ways to improve it is something like adding an agent to an effective chemotherapy regimen: How do you balance the improvements you can attain against the risk of harm you may inadvertently do? As the new editor and co-editor of Neuro-Oncology, we are delighted (and a bit overwhelmed) to have in our hands the premier journal in the field — a journal whose impact score reflects top-tier performance even among the highly regarded general oncology periodicals. We owe a great debt of thanks to Founding Editor Darell D. Bigner, our friend and colleague, for his inestimable contributions to the success of Neuro-Oncology and his continued contributions as a trusted advisor and critic. Not only has he built Neuro-Oncology from the ground up, but he has also secured the support of the Society for Neuro-Oncology, the Japan Society for Neuro-Oncology, the European Association for Neuro-Oncology, and the World Federation of Neuro-Oncology Societies to help create a truly global publication. His early vision for this journal was (and still is) shared by the Pediatric Brain Tumor Foundation of the United States, whose initial grant created the journal and whose continued support still plays a vital role in its operations. We are mindful, too, of the support we receive from the many contributors to this journal — the authors, readers, reviewers, and overseas editors who are responsible for ensuring that Neuro-Oncology is the must-read journal in its field. You are the lifeblood of this journal, for without contributors and readers, we would have no one with whom to share knowledge. Neuro-Oncology is nothing more nor less than a medium, a communications tool linking researchers and practitioners with their peers around the world. And we know that its content must remain interesting, informative, and influential to fulfill that role. Therefore, when we came onboard, one of the first things we wanted to know was who you are and what you want from this journal. Some of you may recall being invited to participate in an online survey. More than 200 of you answered that call, and your input is helping to inform our plans for the next several years of publication. A full half of our readers are neuro-oncologists proper, with another 19% neurosurgeons. But other fields are well represented, too: basic science (14%), pediatrics (10%), radiation oncology (8%), pathology (8%), neurology (7%). .. even …